About FDA

Office of Drug Evaluation I - Division of Neurology Products (DNP)

The Division of Neurology Products (DNP) regulates and reviews Investigational New Drug (IND) applications and marketing applications for drug and biologic products for the treatment of neurological diseases and conditions, such as Alzheimer’s disease, stroke, Parkinson’s disease, Huntington’s disease, epilepsy, migraine headaches, muscular dystrophy, amyotrophic lateral sclerosis, multiple sclerosis, cerebral palsy, dementia, narcolepsy, lennox-gastaut syndrome, and insomnia. 

  • Acting Director: William Dunn, M.D.
  • Deputy Director: Eric Bastings, M.D
  • Deputy Director for Safety: Alice Hughes, M.D.
  • Chief, Project Management Staff: Jacqueline Ware, Pharm.D.
  • Safety Regulatory Project Manager: Kelly Ngan, Pharm.D.

Contact Us
Mailing Address:
 
10903 New Hampshire Avenue, Silver Spring, MD 20993
Building 22, Suite 4346
Phone: (301) 796-2250
Fax: (301) 796-9842

Page Last Updated: 11/21/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.